PCSA
Processa Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.03
−1.22%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
4234.6%
Return on equity
-649.3%
Return on assets
4051.8%
Return on invested capital
0.00x
Asset turnover
-$12.0M
Cash from operations
$0.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026